HSPE1P7

Across TCGA pan-cancer cohorts, HSPE1P7 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated HSPE1P7 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher HSPE1P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HSPE1P7 expression acts as an unfavorable survival marker, although some lineages such as LUSC and TGCT show a favorable association.

PAAD, THYM, and UCEC are the cancer types where HSPE1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Quartile	All	0.336	0.543	<.001	64	view →
THYM	DFS	Quartile	II,III,IV	0.533	0.882	.010	44	view →
UCEC	OS	Median	IV	0.403	0.660	.011	36	view →
KIRP	OS	Quartile	All	0.460	0.847	<.001	33	view →
LUAD	OS	Tertile	All	0.668	0.821	.003	31	view →
LGG	DFS	Median	All	0.635	0.793	<.001	24	view →
LUSC	OS	Median	All	0.813	0.736	.012	21	view →
KIRC	DFS	Tertile	IV	0.217	0.542	.003	16	view →
LIHC	OS	Quartile	II,III,IV	0.206	0.507	.007	11	view →
ACC	DFS	Median	All	0.263	0.604	.004	10	view →
GBM	OS	Tertile	All	0.302	0.458	.009	9	view →
TGCT	DFS	Median	All	0.875	0.736	.032	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

HSPE1P7–PAAD (DFS)

Open the PAAD breakdown →